Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Change in Account Payables (2016 - 2025)

Orthofix Medical's Change in Account Payables history spans 15 years, with the latest figure at $8.3 million for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables rose 42.25% year-over-year to $8.3 million, compared with a TTM value of $2.6 million through Dec 2025, up 146.65%, and an annual FY2025 reading of $2.6 million, up 146.65% over the prior year.
  • Change in Account Payables for Q4 2025 was $8.3 million at Orthofix Medical, up from $3.5 million in the prior quarter.
  • The five-year high for Change in Account Payables was $8.3 million in Q4 2025, with the low at -$6.7 million in Q2 2024.
  • Average Change in Account Payables over 5 years is $610250.0, with a median of -$570500.0 recorded in 2021.
  • Year-over-year, Change in Account Payables crashed 5303.57% in 2021 and then soared 580.41% in 2022.
  • Tracing OFIX's Change in Account Payables over 5 years: stood at $7.2 million in 2021, then tumbled by 123.12% to -$1.7 million in 2022, then skyrocketed by 362.88% to $4.4 million in 2023, then skyrocketed by 31.95% to $5.8 million in 2024, then soared by 42.25% to $8.3 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Change in Account Payables are $8.3 million (Q4 2025), $3.5 million (Q3 2025), and -$6.6 million (Q2 2025).